217
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Maxing Shigan Decoction Mitigates Mycoplasma pneumonia-Induced Pyroptosis in A549 Cells via the NLRP3 Inflammasome

, , ORCID Icon, , , , & show all
Pages 859-867 | Published online: 03 Mar 2021

References

  • Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30:747–809.28539503
  • He J, Liu M, Ye Z, et al. Insights into the pathogenesis of Mycoplasma pneumoniae (review). Mol Med Rep. 2016;14(5):4030–4036. doi:10.3892/mmr.2016.576527667580
  • Lee H, Yun KW, Lee HJ, Choi EH. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018;16:23–34.29212389
  • Tanaka T, Oishi T, Miyata I, et al. Macrolide-resistant Mycoplasma pneumoniae infection, Japan, 2008–2015. Emerg Infect Dis. 2017;23:1703–1706.28930026
  • Wang BJ, Zhang H. Research progress of macrolide-resistant Mycoplasma pneumonia. Lab Med. 2020;35:1070–1074.
  • Long Y, Yang Q, Xiang Y, et al. Nose to brain drug delivery - a promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion. Pharmacol Res. 2020;159:104795.32278035
  • Ren JL, Zhang AH, Wang XJ. Traditional Chinese medicine for COVID-19 treatment. Pharmacol Res. 2020;155:104743.32145402
  • Sugiyama M, Saeki A, Hasebe A, et al. Activation of inflammasomes in dendritic cells and macrophages by Mycoplasma salivarium. Mol Oral Microbiol. 2016;31(3):259–269.26177301
  • Susan L, Fink L, Brad T. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. 2005;73(4):1907–1916.15784530
  • Wang WG, Shi XG, Zhai LX, Wang PJ, Peng XF, Xu YY. Influence of compatibility on content of berberine in Maxingganshi decoction. J Chin Med Mater. 2007;30:602–605.
  • Zuo H, Qian WD. Effect of maxingganshi decoction on the expression of STAT4 and STAT6 in lung tissues of rats with chronic obstructive pulmonary disease. J Hainan Med Univ. 2019;25:892–900.
  • Jiang S, Shi S, Shan WT, Ju AX, Li QH. Study on active compounds from Maxingganshi decoction for treatment of novel coronavirus pneumonia (COVID-19) based on network pharmacology and molecular docking method. Chin Pharmacol Bull. 2020;36:1309–1316.
  • Huang L, Ynag H, Wei Y, Fu Y, Xu G. Dose-response relationship of main components of Ma Xing Shi Gan decoction with relaxing tracheal smooth muscle. Tradit Chin Drug Res Clin Pharmacol. 2015;26:468–471.
  • He GM, Luo WA, Cheng XR, Wei M. UPLC fingerprint chromatography of Maxingshigan decoction. Chin Tradit Pat Med. 2020;42:2792–2795.
  • Deng MH. Treating refractory Mycoplasma pneumonia pneumonia with Maxin Shigan decoction. Clin J Chin Med. 2015;7:90–91.
  • Li GL, Zheng TT, Li LJ. Clinical observation and analysis of Maxing Shigan decoction combined with Azithromycin in the treatment of pediatric Mycoplasma pneumoniae pneumonia. Chin Arch Tradit Chin Med. 2020.
  • Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32(6):956–973. doi:10.1111/j.1574-6976.2008.00129.x18754792
  • Xia X, Wang X, Cheng Z, et al. The role of pyroptosis in cancer: pro-cancer or pro-“host”? Cell Death Dis. 2019;10(9):650. doi:10.1038/s41419-019-1883-831501419
  • Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26(1):99–114. doi:10.1038/s41418-018-0212-630341423
  • Tao HH, Tao XR. Pyroptosis, a novel form of programmed cellular necrosis. J Path Biol. 2017;12:1219–1221.
  • Lee S, Hirohama M, Noguchi M, Nagata K, Kawaguchi A. Influenza A virus infection triggers pyroptosis and apoptosis of respiratory epithelial cells through the Type I interferon signaling pathway in a mutually exclusive manner. J Virol. 2019;26(14):e00396–18. doi:10.1128/JVI.00396-18
  • Taabazuing CY, Okondo MC, Bachovchin DA. Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages. Cell Chem Biol. 2017;24:507–514.28392147
  • Hong L, Cha YJ, Qiao SG, An JZ. Study on protective mechanism of resveratrol against pyroptosis induced by lipopolysaccharide in human lung epithelial cells. Anti Infect Pharm. 2020;17:160–164.
  • Zhang FJ, Ma P. Related research progress of NLRP3 inflammatory corpuscle and pyroptosis. World Latest Med Inform. 2017;17:33–34.
  • Han R, Wu D, Deng S, Liu T, Zhang T, Xu Y. NLRP3 inflammasome induces pyroptosis in lung tissues of radiation-induced lung injury in mice. Clin J Cell Mol Immunol. 2017;33:1206–1211.
  • Segovia JA, Chang TH, Winter VT, et al. NLRP3 is a critical regulator of inflammation and innate immune cell response during Mycoplasma pneumoniae infection. Infect Immun. 2018;86:e00548–17.29061706
  • Zahid A, Li B, Kombe AJK, Jin T, Tao J. Pharmacological inhibitors of the NLRP3 inflammasome. Front Immunol. 2019;10:2538.31749805
  • Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev. 2011;243:206–214.21884178
  • Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42:245–254.27932073
  • Qiu Z, Lei S, Zhao B, et al. NLRP3 inflammasome activation-mediated pyroptosis aggravates myocardial ischemia/reperfusion injury in diabetic rats. Oxid Med Cell Longev. 2017;2017:9743280.29062465
  • Zhang Q, Liu J, Li R, et al. A network pharmacology approach to investigate the anticancer mechanism and potential active ingredients of Rheum palmatum L. against lung cancer via induction of apoptosis. Front Pharmacol. 2020;11:528308.33250766
  • Sun JH, Sun F, Yan B, Li JY, Xin L. Data mining and systematic pharmacology to reveal the mechanisms of traditional Chinese medicine in Mycoplasma pneumoniae pneumonia treatment. Biomed Pharmacother. 2020;125:109900.32028237